| Trial ID: | L1436 |
| Source ID: | NCT00469599
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Treatment of Secondary Hyperparathyroidism in the Uremic Patient
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Secondary Hyperparathyroidism|Chronic Kidney Disease|Vitamin D Deficiency
|
| Interventions: |
DRUG: paricalcitol|DRUG: alfacalcidol
|
| Outcome Measures: |
Primary: The effect of alfacalcidol and paricalcitol on intact parathyroid hormone level and the tendency towards hyperphosphatemia and hypercalcemia, 16 weeks | Secondary: alkaline phosphatase, 25OH-vitamin D,1,25 OH2-vitamin D,calcium x phosphate product, blood pressure, pulse, pulse pressure, parathyroidectomy, pulse wave velocity and pulse wave analysis, initiation of treatment with calcimimetics., 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Zealand University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
86
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2010-10
|
| Results First Posted: |
|
| Last Update Posted: |
2011-04-04
|
| Locations: |
Aalborg University Hospital, Aalborg, 4000, Denmark|Århus University Hospital Skejby, Aarhus, 4000, Denmark|Hospital of Southwest Denmark Esbjerg, Esbjerg, 6700, Denmark|Holbæk County Hospital, Holbæk, 4300, Denmark|Holstebro County Hospital, Holstebro, 7500, Denmark|Odense University Hospital, Odense, 5000, Denmark|Roskilde County Hospital, Roskilde, 4000, Denmark|Viborg County Hospital, Viborg, 8800, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00469599
|
